United Therapeutics (UTHR) PT Lifted to $195 at Wedbush Posts Q4
Wedbush analyst Liana Moussatos reiterated an Outperform rating and boosted her price target on United Therapeutics Corp. (NASDAQ: UTHR) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
